Literature DB >> 10603396

Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro.

M O Eze1, L Yuan, R M Crawford, C M Paranavitana, T L Hadfield, A K Bhattacharjee, R L Warren, D L Hoover.   

Abstract

Entry of opsonized pathogens into phagocytes may benefit or, paradoxically, harm the host. Opsonization may trigger antimicrobial mechanisms such as reactive oxygen or nitric oxide (NO) production but may also provide a safe haven for intracellular replication. Brucellae are natural intramacrophage pathogens of rodents, ruminants, dogs, marine mammals, and humans. We evaluated the role of opsonins in Brucella-macrophage interactions by challenging cultured murine peritoneal macrophages with Brucella melitensis 16M treated with complement- and/or antibody-rich serum. Mouse serum rich in antibody against Brucella lipopolysaccharide (LPS) (aLPS) and human complement-rich serum (HCS) each enhanced the macrophage uptake of brucellae. Combinations of suboptimal levels of aLPS (0. 01%) and HCS (2%) synergistically enhanced uptake. The intracellular fate of ingested bacteria was evaluated with an optimal concentration of gentamicin (2 microg/ml) to control extracellular growth but not kill intracellular bacteria. Bacteria opsonized with aLPS and/or HCS grew equally well inside macrophages in the absence of gamma interferon (IFN-gamma). Macrophage activation with IFN-gamma inhibited replication of both opsonized and nonopsonized brucellae but was less effective in inhibiting replication of nonopsonized bacteria. IFN-gamma treatment of macrophages with opsonized or nonopsonized bacteria enhanced NO production, which was blocked by N(G)-monomethyl L-arginine (MMLA), an NO synthesis inhibitor. MMLA also partially blocked IFN-gamma-mediated bacterial growth inhibition. These studies suggest that primary murine macrophages have limited ability to control infection with B. melitensis, even when activated by IFN-gamma in the presence of highly opsonic concentrations of antibody and complement. Additional cellular immune responses, e.g., those mediated by cytotoxic T cells, may play more important roles in the control of murine brucellosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10603396      PMCID: PMC97129          DOI: 10.1128/IAI.68.1.257-263.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  Resistance to intracellular infection.

Authors:  G B Mackaness
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

2.  Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b.

Authors:  S L Newman; R B Johnston
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes.

Authors:  P H Elzer; R W Phillips; G T Robertson; R M Roop
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes.

Authors:  E J Young; M Borchert; F L Kretzer; D M Musher
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

5.  Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.

Authors:  A Gross; S Spiesser; A Terraza; B Rouot; E Caron; J Dornand
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

6.  Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages.

Authors:  E S Drazek; H S Houng; R M Crawford; T L Hadfield; D L Hoover; R L Warren
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes.

Authors:  J Pizarro-Cerdá; S Méresse; R G Parton; G van der Goot; A Sola-Landa; I Lopez-Goñi; E Moreno; J P Gorvel
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediates.

Authors:  J N Samsom; J A Langermans; P H Groeneveld; R van Furth
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  34 in total

1.  Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.

Authors:  Juliana Cassataro; Silvia M Estein; Karina A Pasquevich; Carlos A Velikovsky; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.

Authors:  Juan Manuel Spera; Juan Esteban Ugalde; Juan Mucci; Diego J Comerci; Rodolfo Augusto Ugalde
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

3.  Brucella alters the immune response in a prpA-dependent manner.

Authors:  Juan M Spera; Diego J Comerci; Juan E Ugalde
Journal:  Microb Pathog       Date:  2014-02-04       Impact factor: 3.738

4.  Identification of Brucella abortus virulence proteins that modulate the host immune response.

Authors:  Yufei Wang; Zeliang Chen; Yefeng Qiu; Yuehua Ke; Jie Xu; Xitong Yuan; Xianbo Li; Simei Fu; Mingquan Cui; Yongfei Xie; Xinying Du; Zhoujia Wang; Liuyu Huang
Journal:  Bioengineered       Date:  2012-06-29       Impact factor: 3.269

5.  IFN-γ targets macrophage-mediated immune responses toward Staphylococcus aureus.

Authors:  Mallary C Greenlee-Wacker; William M Nauseef
Journal:  J Leukoc Biol       Date:  2016-10-05       Impact factor: 4.962

6.  Artificial Selection for Pathogenicity Mutations in Staphylococcus aureus Identifies Novel Factors Relevant to Chronic Infection.

Authors:  Kathryn McLean; Elizabeth A Holmes; Kelsi Penewit; Duankun K Lee; Samantha R Hardy; Mingxin Ren; Maxwell P Krist; Kevin Huang; Adam Waalkes; Stephen J Salipante
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

7.  Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.

Authors:  J Xu; Y Qiu; M Cui; Y Ke; Q Zhen; X Yuan; Y Yu; X Du; J Yuan; H Song; Z Wang; G Gao; S Yu; Y Wang; L Huang; Z Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-15       Impact factor: 3.267

8.  Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Authors:  Marina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

9.  Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.

Authors:  Carlos A Velikovsky; Fernando A Goldbaum; Juliana Cassataro; Silvia Estein; Raúl A Bowden; Laura Bruno; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages.

Authors:  Stacy M Townsend; Harvey A Pollack; Ignacio Gonzalez-Gomez; Hiroyuki Shimada; Julie L Badger
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.